Cardiovascular risk factors in the urban Mexican population: The FRIMEX study

Public Health

Volumn 121, Issue 5, 2007, Pages 378-384

  Meaney, E ^a   Lara Esqueda, A ^b   Ceballos Reyes, G M ^c   Asbun, J ^c   Vela, A ^a   Martinez Marroquin Y ^b   Lopez V ^a   Meaney, A ^a   de la Cabada Tamez, E ^b   Velázquez Monroy, Ó ^b   Tapia Conyer, R ^d  

^a HOSPITAL REGIONAL 1 DE OCTUBRE   (Mexico)

^b Adult and Aged Adult Health Program   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^d Secretariat of Health   (Mexico)

Author keywords

Cardiovascular risk factors; Diabetes; Hypercholesterolaemia; Obesity; Smoking; Systemic arterial hypertension

Indexed keywords

CHOLESTEROL; GLUCOSE;

CARDIOVASCULAR DISEASE; DIABETES; EPIDEMIOLOGY; GENDER ISSUE; HEALTH RISK; HEALTH SURVEY; HYPERTENSION; MORTALITY; OBESITY; RISK FACTOR; SMOKING; URBAN POPULATION;

ADULT; AGED; ARTICLE; AWARENESS; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE CONTROL; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH SURVEY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MEXICO; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; SMOKING; URBAN AREA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CARDIOVASCULAR DISEASES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MEXICO; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS; SMOKING; URBAN HEALTH;

MEXICO [NORTH AMERICA]; NORTH AMERICA;

EID: 33947641542     PISSN: 00333506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.puhe.2006.11.008     Document Type: Article

References (19)

1. Causas de mortalidad en México, 2000. Estadísticas de mortalidad. México, D.F.: Secretaría de Salud; 2000. Available at: 〈http://www.ssa.gob.mx〉 [accessed June 2005].
2. Posadas-Romero C., Sepúlveda J., Tapia-Conyer R., Magos C., Cardoso-Saldana G., Zamora-Gonzalez J., et al. Values of serum cholesterol in the Mexican population. Salud Pública Mex 34 (1992) 157-167
3. Dirección General de Epidemiología. Encuesta nacional de enfermedades crónicas. México, D.F.: Secretaría de Salud; 1994. Available at: 〈http://www.ssa.gob.mx〉 [accessed May 2005].
4. Dirección General de Epidemiología. Encuesta nacional de adicciones. México, D.F.: Secretaría de Salud; 1998.
5. Velazquez Monroy O., Rosas Peralta M., Lara Esqueda A., Pastelin Hernandez G., Attie F., and Tapia Conyer R. Grupo Encuesta Nacional de Salud 2000. Arterial hypertension in Mexico: results of the National Health Survey 2000. Arch Cardiol Mex 72 (2002) 71-84
6. Rosas Peralta M., Lara Esqueda A., Pastelin Hernandez G., Velazquez Monroy O., Martinez Reding J., Mendez Ortiz A., et al. National re-survey of arterial hypertension (RENAHTA). Mexican consolidation of the cardiovascular risk factors. National follow-up cohort. Arch Cardiol Mex 75 (2005) 96-111
7. American Heart Association. Recommendations for human blood pressure determination by sphygmomanometers. Report of a special task force appointed by the steering committee. Circulation 1988;77:A501-14.
8. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
9. Cruickshank J.K., Mbanya J.C., Wilks R., Balkau B., Forrester T., Anderson S.G., et al. Hypertension in four African-origin populations: current 'rule of the halves', quality of blood pressure control and attributable risk of cardiovascular disease. J Hypertens 19 (2001) 41-46
10. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
11. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005;28(Suppl 1):S37-42.
12. Smith Jr. S.C., Blair S.N., Bonow R.O., Brass L.M., Cerqueira M.D., Dracup K., et al. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 38 (2001) 1581-1583
13. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J 1998;19:1434-503.
14. Rivera J.A., Barquera S., Campirano F., Campos I., Safdie M., and Tovar V. Epidemiological and nutritional transition in Mexico: rapid increase of non-communicable chronic diseases and obesity. Public Health Nutr 5 1A (2002) 113-122
15. Aguilar-Salinas C.A., Rojas R., Gomez-Perez F.J., Garcia E., Valles V., Rios-Torres J.M., et al. Prevalence and characteristics of early-onset type 2 diabetes in Mexico. Am J Med 113 (2002) 569-574
16. Aguilar-Salinas C.A., Rojas R., Gomez-Perez F.J., Valles V., Rios-Torres J.M., Franco A., et al. High prevalence of metabolic syndrome in Mexico. Arch Med Res 35 (2004) 76-81
17. Cruickshank J.K. Worldwide prevalence, awareness, treatment and control of hypertension. J Hypertens 22 (2004) 21-24
18. Kearney P.M., Whelton M., Reynolds K., Whelton P.K., and He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 22 (2004) 11-19
19. Tapia-Conyer R., Kuri-Morales P., and Hoy-Gutiérrez M.J. Epidemiologic overview of smoking in Mexico. Salud Pública Mex 43 (2002) 478-484